BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37872559)

  • 1. Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.
    Müller AR; Luijten MAJ; Haverman L; de Ranitz-Greven WL; Janssens P; Rietman AB; Hoopen LWT; de Graaff LCG; de Wit MC; Jansen AC; Gipson T; Capal JK; de Vries PJ; van Eeghen AM
    BMC Med; 2023 Oct; 21(1):401. PubMed ID: 37872559
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.
    Müller AR; Luijten MAJ; Haverman L; de Ranitz-Greven WL; Janssens P; Rietman AB; Ten Hoopen LW; de Graaff LCG; de Wit MC; Jansen AC; Gipson T; Capal JK; de Vries PJ; van Eeghen AM
    BMC Med; 2023 Aug; 21(1):298. PubMed ID: 37553648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance.
    Alsowat D; Zak M; McCoy B; Kabir N; Al-Mehmadi S; Chan V; Whitney R
    Pediatr Neurol; 2020 Jan; 102():44-48. PubMed ID: 31362847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
    Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
    Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis: a review of the past, present, and future.
    Uysal SP; Şahin M
    Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, cellular, and molecular characterisation of cardiac rhabdomyoma in tuberous sclerosis.
    Al Kindi HN; Ibrahim AM; Roshdy M; Abdelghany BS; Yehia D; Masoud AN; Simry W; Aguib Y; Yacoub MH
    Cardiol Young; 2021 Aug; 31(8):1297-1305. PubMed ID: 33602381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma.
    Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
    Hum Pathol; 2022 Nov; 129():123-139. PubMed ID: 36115585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Cell Carcinoma in Tuberous Sclerosis Complex.
    Henske EP; Cornejo KM; Wu CL
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex.
    Klonowska K; Giannikou K; Grevelink JM; Boeszoermenyi B; Thorner AR; Herbert ZT; Afrin A; Treichel AM; Hamieh L; Kotulska K; Jozwiak S; Moss J; Darling TN; Kwiatkowski DJ
    Am J Hum Genet; 2023 Jun; 110(6):979-988. PubMed ID: 37141891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphedema in tuberous sclerosis complex.
    Geffrey AL; Shinnick JE; Staley BA; Boronat S; Thiele EA
    Am J Med Genet A; 2014 Jun; 164A(6):1438-42. PubMed ID: 24668795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Self-Injurious Behavior, Aggression, and Psychogenic Non-Epileptic Seizures in Patients With Tuberous Sclerosis: A Case Report With a Review of Literature.
    Ortiz JF; Ruxmohan S; Gomez J; Lalama HA; Taylor A; Smith DW
    Cureus; 2020 Nov; 12(11):e11715. PubMed ID: 33391947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal adversities in tuberous sclerosis complex: Determinants and neurodevelopmental outcomes.
    Zhang AXD; Liang H; McEwen FS; Tye C; Woodhouse E; Underwood L; Shephard E; Sheerin F; ; Bolton PF
    Dev Med Child Neurol; 2022 Oct; 64(10):1237-1245. PubMed ID: 35366331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma.
    Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
    Hum Pathol; 2023 Mar; 133():136-152. PubMed ID: 36894367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in the dermatological manifestations of tuberous sclerosis complex and the potential effects on diagnosis and care.
    Pounders AJ; Rushing GV; Mahida S; Nonyane BAS; Thomas EA; Tameez RS; Gipson TT
    Ther Adv Rare Dis; 2022; 3():26330040221140125. PubMed ID: 37180419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological Characterization of Tuberous Sclerosis: a Delay in the Nucleo-Shuttling of ATM May Be Responsible for Radiosensitivity.
    Ferlazzo ML; Bach-Tobdji MKE; Djerad A; Sonzogni L; Devic C; Granzotto A; Bodgi L; Bachelet JT; Djefal-Kerrar A; Hennequin C; Foray N
    Mol Neurobiol; 2018 Jun; 55(6):4973-4983. PubMed ID: 28786016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early patterns of functional brain development associated with autism spectrum disorder in tuberous sclerosis complex.
    Dickinson A; Varcin KJ; Sahin M; Nelson CA; Jeste SS
    Autism Res; 2019 Dec; 12(12):1758-1773. PubMed ID: 31419043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.
    Okamoto SI; Prikhodko O; Pina-Crespo J; Adame A; McKercher SR; Brill LM; Nakanishi N; Oh CK; Nakamura T; Masliah E; Lipton SA
    Neurobiol Dis; 2019 Jul; 127():390-397. PubMed ID: 30928642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.